As Covid-19 cases cross 24 million globally, a look at 5 much-awaited vaccines
Scientists across the world are working for an affordable Covid-19 vaccine as the infection tally has crossed the 24 million-mark worldwide on Thursday. As many as 822,000 people have died due to the virus.
United States has the highest number of cases in the world (5.9 million), followed by Brazil (3.72 million), India (3.31 million).
Here is a look at Covid-19 vaccines under trial:
Oxford’s ChAdOx1 nCoV-19 vaccine
The vaccine is being developed by University of Oxford in association with Pharmaceutical company AstraZeneca. The Phase II clinical trial of the vaccine, being manufactured by the city-based Serum Institute of India (SII) in India, began at a medical college and hospital in Pune. This vaccine is expected to be out till December 2020 and the estimated price of the vaccine will be $4 ( ₹295).
American drug company Moderna’s mRNA-1273 vaccine is in the third phase of its trial. The sample size for this trial is 30,000 and it is expected to be complete by September-end. The biotechnology company Moderna plans to roll out the vaccine by the end of this year. Its price is expected to be between Rs1,800 and Rs23,00.
Also Watch | Covid vaccine: India, Russia in talks after Putin declares drug ready-for-use
Vaccine by China’s Sinopharm
Chinese company Sinopharm has announced that it will launch a Covid-19 vaccine by the end of 2020. The third phase of this potential vaccine’s trial is underway in the UAE. Two doses of this vaccine will reportedly cost ₹10,700.
CanSino Biologics Inc’s vaccine Ad5-nCoV
According to another Chinese company, CanSino Biologics Inc, its Covid-19 vaccine Ad5-nCoV has got patent rights. This vaccine has been developed in association with Beijing Institute of Biotechnology. This vaccine too is expected to be launched by the end of this year. There has been no revelation about the price of the vaccine.
Russia’s Sputnik V
Russia had claimed to have launched the world’s first Covid-19 vaccine, Sputnik V, on August 11. Russian President Vladimir Putin had said that the vaccine was safe and showed “stable immunity” against coronavirus. However, the vaccine has not undergone the third stage of trail. As many as 40,000 volunteers will participate in the trial. According to Moscow-based Gamaleya Institute, the vaccine will be out by September-end. The price of the vaccine has not been announced yet.
Ukraine said it came under "massive bombardment" Saturday from neighbouring Belarus, a Russian ally not officially involved in the conflict, the day after announcing a retreat from the strategic city of Severodonetsk. Belarus has provided logistic support to Moscow since the February 24 invasion, particularly in the first few weeks, and like Russia has been targeted by Western sanctions -- but is officially not involved in the conflict.
President Joe Biden on Saturday signed into law the first significant federal bill on gun safety in decades, saying that while it falls short of what's really needed it will "save lives. While this bill doesn't do everything I want, it does include actions I've long called for that are going to save lives," he said at the White House before leaving for major diplomatic summits in Europe.
Iran's talks aimed at reviving the 2015 nuclear deal with the US will restart in the “coming days,” European Union foreign policy chief Josep Borrell Fontelles said. The negotiations “have to be finished, three months have passed,” Borrell said. Iranian Foreign Minister Hossein Amirabdollahian reiterated his call to the Biden administration to take a “realistic and fair” approach to help reach an agreement. The US pulling out of the Iran accord has increased tensions between the countries.
China deployed “aerial and ground forces” to monitor an US P-8A Poseidon reconnaissance aircraft, which flew over the Taiwan Strait on Friday in the backdrop of large scale Chinese armed forces' military drills around the self-ruled island of Taiwan earlier this week. The US Navy's reconnaissance aircraft flew over the Taiwan Strait on Friday in what the US Indo-Pacific Command described as a demonstration of the US's “commitment to a free and open Indo-Pacific”.
When Ontario's Conservative Party premier Doug Ford was first given the mandate to lead Canada's most populous province, he did not have a single Indo-Canadian minister, though he rectified that omission later. Beginning the second term as premier, Ford appointed two Indo-Canadians to significant portfolios. Sarkaria, who represents the riding (as constituencies are called in Canada) of Brampton South, tweeted, “I'm truly honoured and grateful to be chosen for this important role.”